Simvastatin Significantly Reduced Alcohol-Induced Cardiac Damage in Adolescent Mice

This study demonstrated that Simvastatin, an FDA approved and easily accessible drug, may be beneficial in lowering the prevalence of alcohol-induced cardiovascular diseases (especially in adolescents) which will have a huge financial implication on health systems worldwide.PMID:38261135 | PMC:PMC10838240 | DOI:10.1007/s12012-023-09821-6
Source: Cardiovascular Toxicology - Category: Cardiology Authors: Source Type: research